person

Simon V. W.

Country
Belgium
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
54
Sites with multiple studies

Has run more than one trial at 54 of 222 partner sites.

Specializations

Urological Oncology

The investigator specializes in treating advanced urological malignancies, with particular focus on muscle-invasive urothelial carcinoma of the bladder. Their research encompasses innovative therapeutic approaches for patients who cannot receive traditional platinum-based treatments.

  • Bladder Cancer Management
  • Pre-surgical Treatment Strategies
  • Alternative Treatment Pathways

Their work involves evaluating novel therapeutic combinations for patients scheduled for radical cystectomy.

Kidney Cancer Research

The investigator focuses on advancing treatment options for renal cell carcinoma, particularly in cases where previous therapies have proven insufficient. Their expertise extends to managing complex cases requiring multiple lines of treatment.

  • Advanced Renal Cell Carcinoma
  • Combination Therapy Approaches
  • Treatment-Resistant Disease

Their research evaluates innovative therapeutic combinations for patients with progressive disease.

Immunotherapy Applications

The investigator has developed expertise in applying immune checkpoint inhibitor therapies across urological cancers. Their work explores both standalone immunotherapy treatments and combination approaches with targeted agents.

  • Novel Immunotherapy Combinations
  • Sequential Treatment Strategies
  • Patient Response Assessment

Their research examines optimal therapeutic sequencing and combination strategies in urological malignancies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.